Insights Articles
Article
How Calif. Ruling Defines Drug Cos.' R&D Responsibilities
August 17, 2026
| Law360
Authors:
Person Mark Sentenac
Mark Sentenac
Partner
Person Simran Modi
Simran Modi
Associate

Mark Sentenac and Simran Modi analyze a recent California ruling that clarifies the scope of pharmaceutical companies' research and development responsibilities in Law360. The article discusses how the decision may influence drug manufacturers' obligations in the R&D process and shape future litigation involving pharmaceutical product development.

Read More

Authors
Person Mark Sentenac
Mark Sentenac
Partner
Product Liability & Mass Torts
Person Simran Modi
Simran Modi
Associate
Product Liability & Mass Torts
Related Capabilities
Product Liability MDL & Coordinating Counsel Leadership FDA & Life Sciences Artificial Intelligence (AI) & Machine Learning Consumer Products Litigation Tech Torts Pharmaceutical & Medical Device Innovative Drug, Biologic & Device Development Life Sciences & Healthcare
Explore King & Spalding
a blue and green background
Capabilities
Product Liability
Learn More
a blue and green background
Capabilities
MDL & Coordinating Counsel Leadership
Learn More

The Best and Latest Insights
All in One Place.

Subscribe